The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meinl, E.
Right arrow Articles by Hivroz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meinl, E.
Right arrow Articles by Hivroz, C.
The Journal of Immunology, 2000, 165: 3578-3583.
Copyright © 2000 by The American Association of Immunologists

Differential Requirement of ZAP-70 for CD2-Mediated Activation Pathways of Mature Human T Cells1

Edgar Meinl2,*,{dagger}, Doris Lengenfelder*, Norbert Blank{ddagger}, Rainer Pirzer*, Luis Barata§ and Claire Hivroz

* Institute for Clinical and Molecular Virology, University Erlangen-Nürnberg, Erlangen, Germany; {dagger} Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Germany and Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University, Munich, Germany; {ddagger} Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nürnberg, Erlangen, Germany; § Primary Immunodeficiencies Unit, Department of Allergy and Clinical Immunology, Coimbra Paediatric Hospital, Coimbra, Portugal; and Institut National de la Santé et de la Recherche Médicale Unit 520, Institut Curie, Paris, France

This study addresses the role of the tyrosine kinase ZAP-70 in CD2-mediated T cell activation. Patients lacking ZAP-70 have few mature CD8+ T cells and high numbers of CD4+ T cells that are nonfunctional upon TCR triggering. Such a patient with a homozygous deletion in the zap-70 gene that resulted in the complete absence of ZAP-70 protein expression has been identified. Expression of the tyrosine kinases Lck, Fyn, and Syk was normal. The patient’s T cells were activated with two different pairs of mitogenic mAbs. CD2-induced phosphorylation of the {zeta}-chain and influx of Ca2+ was defective in the ZAP-70-deficient T cells, whereas CD2-induced phosphorylation of several other proteins, including Syk, was not affected. CD2-induced proliferation as well as production of TNF-{alpha} and IFN-{gamma} was abrogated in ZAP-70-deficient T cells, whereas PMA plus ionomycin induced normal activation of these cells. Together, this study shows that CD2-activation triggers ZAP-70-dependent and -independent pathways. Deletion of ZAP-70 affected CD2- and CD3-mediated proliferation and cytokine production in a similar way, suggesting that one of the different CD2 pathways converges with a CD3 pathway at or upstream of the activation of ZAP-70.




This article has been cited by other articles:


Home page
BloodHome page
M. Steinberg, O. Adjali, L. Swainson, P. Merida, V. D. Bartolo, L. Pelletier, N. Taylor, and N. Noraz
T-cell receptor-induced phosphorylation of the {zeta} chain is efficiently promoted by ZAP-70 but not Syk
Blood, August 1, 2004; 104(3): 760 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Dumont, N. Blanchard, V. Di Bartolo, N. Lezot, E. Dufour, S. Jauliac, and C. Hivroz
TCR/CD3 Down-Modulation and {zeta} Degradation Are Regulated by ZAP-70
J. Immunol., August 15, 2002; 169(4): 1705 - 1712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. P. Martelli, J. Boomer, M. Bu, and B. E. Bierer
T Cell Regulation of p62dok (Dok1) Association with Crk-L
J. Biol. Chem., November 30, 2001; 276(49): 45654 - 45661.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Meinl, T. Derfuss, R. Pirzer, N. Blank, D. Lengenfelder, A. Blancher, F. Le Deist, B. Fleckenstein, and C. Hivroz
Herpesvirus saimiri Replaces ZAP-70 for CD3- and CD2-mediated T Cell Activation
J. Biol. Chem., September 28, 2001; 276(40): 36902 - 36908.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.